We are live on ! Find out more
NPF

Norris Perne & French Portfolio holdings

AUM $1.71B
1-Year Est. Return 30.87%
This Fund
S&P 500
This Quarter Est. Return
-13.86%
1 Year Est. Return
+30.87%
3 Year Est. Return
+78.29%
5 Year Est. Return
+102.93%
10 Year Est. Return
+464.45%
AUM
$1.04B
AUM Growth
-$196M
Cap. Flow
-$13.1M
Cap. Flow %
-1.26%
Top 10 Hldgs %
28.25%
Holding
161
New
3
Increased
62
Reduced
34
Closed
27

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$6.19M
2
BALL icon
Ball Corp
BALL
+$5.77M
3
SSNC icon
SS&C Technologies
SSNC
+$5.53M
4
V icon
Visa
V
+$4.31M
5
ECL icon
Ecolab
ECL
+$4.27M

Sector Composition

Rank Sector Weight
1 Technology 26.44%
2 Healthcare 16.32%
3 Industrials 14.54%
4 Consumer Discretionary 9.73%
5 Financials 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.71T
$57.2M 5.49%
222,614
+3,821
+2% +$1.04M
BRK.B icon
2
Berkshire Hathaway Class B
BRK.B
$1.13T
$37M 3.56%
135,600
+1,319
+1% +$414K
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.33T
$32.3M 3.11%
296,700
+4,400
+2% +$518K
LNG icon
4
Cheniere Energy
LNG
$52.9B
$27.3M 2.63%
205,511
-773
-0.4% -$105K
IVV icon
5
iShares Core S&P 500 ETF
IVV
$904B
$25M 2.4%
65,929
-2,685
-4% -$1.1M
LIN icon
6
Linde
LIN
$226B
$24.7M 2.37%
85,805
+791
+0.9% +$247K
V icon
7
Visa
V
$677B
$23.4M 2.24%
118,636
+20,838
+21% +$4.31M
BALL icon
8
Ball Corp
BALL
$16.8B
$23.2M 2.23%
337,199
+75,990
+29% +$5.77M
MRK icon
9
Merck
MRK
$318B
$22M 2.12%
241,756
-195
-0.1% -$17.3K
ECL icon
10
Ecolab
ECL
$79.9B
$22M 2.11%
142,852
+25,767
+22% +$4.27M
CRL icon
11
Charles River Laboratories
CRL
$12.8B
$21.5M 2.07%
100,483
+25,343
+34% +$6.19M
BMY icon
12
Bristol-Myers Squibb
BMY
$132B
$21M 2.02%
272,832
-8,202
-3% -$625K
AMAT icon
13
Applied Materials
AMAT
$428B
$19.7M 1.9%
216,923
+2,548
+1% +$279K
ADBE icon
14
Adobe
ADBE
$105B
$19.4M 1.86%
52,871
+816
+2% +$332K
ALSN icon
15
Allison Transmission
ALSN
$9.82B
$19.2M 1.85%
500,045
+86,574
+21% +$3.31M
VRSK icon
16
Verisk Analytics
VRSK
$25B
$18.8M 1.81%
108,858
+1,417
+1% +$264K
QCOM icon
17
Qualcomm
QCOM
$176B
$18.7M 1.8%
146,348
+3,519
+2% +$478K
ATVI
18
DELISTED
Activision Blizzard
ATVI
$18.7M 1.79%
239,855
+2,961
+1% +$230K
COST icon
19
Costco
COST
$420B
$18.1M 1.74%
37,784
-14,922
-28% -$7.57M
QLYS icon
20
Qualys
QLYS
$6.35B
$17.9M 1.72%
141,864
+18,339
+15% +$2.4M
PWR icon
21
Quanta Services
PWR
$101B
$17.8M 1.71%
141,723
+1,901
+1% +$233K
UNP icon
22
Union Pacific
UNP
$174B
$17.5M 1.68%
82,015
+876
+1% +$199K
DHR icon
23
Danaher
DHR
$144B
$17.3M 1.66%
77,092
+1,828
+2% +$421K
HD icon
24
Home Depot
HD
$355B
$16.7M 1.61%
61,056
+1,062
+2% +$314K
OGN icon
25
Organon & Co
OGN
$3.57B
$16.5M 1.58%
487,875
+4,761
+1% +$167K

Similar funds

Norris Perne & French's Q2 2022 Portfolio in Review

As of Q2 2022, Norris Perne & French held 161 positions worth $1.04B, down 16% from $1.24B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Norris Perne & French's Q2 2022 filing shows 3 new, 62 increased, 34 reduced and 27 closed positions. Its largest new stake was IBM: 4,121 shares worth $582K. The largest sale was Arista Networks, an estimated $23.1M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 29% a quarter earlier, followed by Healthcare and Industrials.

  • Norris Perne & French's largest Q2 2022 buy was IBM: 4,121 shares worth $582K.
  • Norris Perne & French added most to Charles River Laboratories in Q2 2022, an estimated $6.19M increase.
  • Norris Perne & French's biggest Q2 2022 reduction was Johnson & Johnson, cutting an estimated $9.33M.
  • Norris Perne & French fully exited Arista Networks in Q2 2022, selling an estimated $23.1M.
  • Norris Perne & French's ten largest holdings make up 28% of its $1.04B portfolio in Q2 2022.
  • Norris Perne & French opened 3 new positions and closed 27 in Q2 2022.
  • Norris Perne & French's portfolio value fell 16% quarter-over-quarter to $1.04B.

Based on Norris Perne & French's 13F filing for Q2 2022, filed 11 Aug 2022.